-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - 6 doses with stable dosing for further 3 weeks 5.4 sprays/day Placebo 5.3 sprays/day NA NA NA NA 5 Short … 0.08 mg CBD) Placebo (olive oil) Mean dose at postintervention evaluation was 4.3 drops NA NA NA NA 8 Short … mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg/day Placebo 3 tablets/day NA NA NA NA 7 Short … day, crossover to nabilone 250 ug titrated up to a max of 2 mg/day Max dose 240 mg/day NA NA NA NA 6 Short … titrated to max 12 sprays per day 8 sprays (range 3 to 12 sprays) Placebo 11 sprays NA NA NA NA 4 Short
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-nonopioid-pharm-chronic-pain.pdf
July 01, 2022 - THC/CBD
versus placebo
short-term
Cannabis was associated
with a moderate
improvement in short-term … Pregabalin
versus
amitriptyline
versus
combination short-
term
No studies 1 RCT (n=110) from … Pregabalin
versus placebo
short-term
Pregabalin was associated
with a small reduction in
pain … Desipramine
versus active
placebo short-
term
No overall improvement in
pain with desipramine, … TCAs short-
term
Dry mouth more likely with
amitriptyline
• SOE: Insufficient, based
on 1 RCT
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
January 01, 2024 - daily Max daily dose of 18 drops per day (15 mg THC/90 mg CBD) Placebo NR NA NA 16, with 2 week washout Short … 6 doses with stable dosing for further 3 weeks 5.4 sprays/day Placebo 5.3 sprays/day NA NA NA NA 5 Short … 0.08 mg CBD) Placebo (olive oil) Mean dose at postintervention evaluation was 4.3 drops NA NA NA NA 8 Short … mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg/day Placebo 3 tablets/day NA NA NA NA 7 Short … Max dose six drops three times daily Placebo NA 16 Short NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - 6 doses with stable dosing for further 3 weeks 5.4 sprays/day Placebo 5.3 sprays/day NA NA NA NA 5 Short … 0.08 mg CBD) Placebo (olive oil) Mean dose at postintervention evaluation was 4.3 drops NA NA NA NA 8 Short … mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg/day Placebo 3 tablets/day NA NA NA NA 7 Short … titrated to max 12 sprays per day 8 sprays (range 3 to 12 sprays) Placebo 11 sprays NA NA NA NA 4 Short … Max dose six drops three times daily Placebo NA 16 Short NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - 6 doses with stable dosing for further 3 weeks 5.4 sprays/day Placebo 5.3 sprays/day NA NA NA NA 5 Short … 0.08 mg CBD) Placebo (olive oil) Mean dose at postintervention evaluation was 4.3 drops NA NA NA NA 8 Short … mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg/day Placebo 3 tablets/day NA NA NA NA 7 Short … titrated to max 12 sprays per day 8 sprays (range 3 to 12 sprays) Placebo 11 sprays NA NA NA NA 4 Short … Max dose six drops three times daily Placebo NA 16 Short NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - 6 doses with stable dosing for further 3 weeks 5.4 sprays/day Placebo 5.3 sprays/day NA NA NA NA 5 Short … 0.08 mg CBD) Placebo (olive oil) Mean dose at postintervention evaluation was 4.3 drops NA NA NA NA 8 Short … mg 3 times/day; days 11 to 52: 8 mg 3/day Range: 15 to 24 mg/day Placebo 3 tablets/day NA NA NA NA 7 Short … titrated to max 12 sprays per day 8 sprays (range 3 to 12 sprays) Placebo 11 sprays NA NA NA NA 4 Short … Max dose six drops three times daily Placebo NA 16 Short NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR
-
effectivehealthcare.ahrq.gov/sites/default/files/delilberative-methods-design-gupta.pdf
May 29, 2025 - deliberation activities
Outputs
o Tangibles produced as result of activities
Outcomes
o Short-Term … based on the activities, outputs, and short-term outcomes
o Long-Term
Expected changes in policy … , culture, conditions, etc. based on the
activities, outputs, short- and mid-term outcomes
Table:
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
March 01, 2022 - ES, SOE Function
Intermediate
ES, SOE Function
Long-Term
ES, SOE Pain
Short-Term
ES, SOE Pain
Intermediate … ES, SOE Function Intermediate
ES, SOE Function Long-Term
ES, SOE Pain
Short-Term
ES, SOE Pain Intermediate … and anxiety), quality of life, opioid use, sleep quality/interference, health care utilization
Time: Short … : 1 to <6 Months
Change in Overall Function: Comparable THC to CBD Ratio Versus Placebo
Short-Term … Placebo
Short-term: 1 to <6 months
Living Review
28
Entering third year since initial review.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Short bowel
syndrome. [internet]. … A new
treatment for patients with short-bowel syndrome. … FDA
approves Gattex to treat short bowel syndrome.
[internet]. Silver Spring (MD): U.S. … Short bowel syndrome. In: PubMed
Health [database online]. … Short bowel syndrome (SBS). [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - bowel syndrome
Intervention
Teduglutide (Gattex) for treatment of short bowel syndrome
Short … Short bowel syndrome. [internet]. … A new
treatment for patients with short-bowel syndrome. … Pediatric short-bowel syndrome: the cost of
comprehensive care. … Children's Hospital Boston: short bowel syndrome.
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
May 01, 2017 - benefits, whereas
agility training shows short- and
long-term benefits … • Glucosamine alone: No RCTs met inclusion criteria
for short- or medium-term outcomes. … No studies assessed effects of
balneotherapy on short- or long-term outcomes. … No RCTs on short-
term effects of footwear were identified. … (2) I(1) I(1)
Long-term I(1) I(0)
Cane
Short-term I(1) I(1) I(1)
Weight loss
Short-term I(2) I(2
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
May 29, 2025 - Exclusion: NR Substance misuse Parent caregiver Short-term facility: 15
Long-term facility: 16 Short-term … facility: 37
Long-term facility: 24 Short-term facility: 37
Long-term facility: 24 A. … (Short-term facility: n=19; Long-term facility: n=12)
B. … Parent sessions typically included one discharge planning session in the short-term setting and periodic … (Short-term facility: n=18; Long-term facility: n=12) English; Spanish Not explicitly - Parent SMART
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_consumer.pdf
August 01, 2017 - Medicines
Your health care professional may suggest a medicine for your
insomnia disorder in the short … But, these medicines are only
meant to be taken for short periods of time (4 weeks to 3 months). … term Yes, possibly serious
Zolpidem (Ambien®) Yes, in the short term Yes, possibly serious
Zaleplon … ®) Yes, in the short term Yes, possibly serious
Melatonin agonist
Ramelteon (Rozerem®) Maybe, in the … short term Yes, possibly serious
Antidepressant
Doxepin (Silenor®) Maybe, in the short term Yes, possibly
-
effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
January 01, 2012 - bowel syndrome
Teduglutide (Gattex) for Treatment of Short Bowel Syndrome
Short bowel syndrome … Short bowel syndrome. [internet]. … A
new treatment for patients with short-bowel
syndrome. … Pediatric short-bowel syndrome: the
cost of comprehensive care. … Short bowel syndrome. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0376-140408.pdf
November 06, 2013 - Intervention(s):
Psychiatric hospitalization: ultra-short (1 to 4 days), short (5 to 6), longer ( … 10 days
Transition support services after discharge (e.g., discharge services, follow-up
calls, short-term … The comparative effectiveness of short- and long-term psychiatric hospitalizations for persons with
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-251-integrated-pain-management-evidence-summary.pdf
October 01, 2021 - • Comprehensive programs were associated with improvement in function in the
short term compared … primary outcomes of function, pain, and changes in
opioid use immediately after the intervention, at short … Telephone-CBT
Pain
(Effect
Size/SOE)a
Postintervention None
++ No evidence No evidence
Short … Effect
Size/SOE)a
Postintervention Small
++
None
++
Moderate
+
Moderatec
+
None
+
Short … Effect
Size/SOE)a
Postintervention Moderate
+
None
++
Moderateb
+
None
+
None
+
Short
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0655-131114.pdf
May 22, 2013 - professional/researcher on behalf of an Organization
Nomination The nominator is interested in the short-term … Intervention(s): Psychological and/or pharmacological interventions or treatments that
have short- … Comparator(s): All other treatment options
Outcome(s): Increases in positive short- and long-term outcomes … conduct disorder
(CD), and disruptive behavior disorder not otherwise specified (DBD NOS), what is
the short-term
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
June 01, 2013 - *Teduglutide (Gattex) for treatment of short bowel syndrome Moderately high
4. … Short bowel syndrome.
[internet]. … A new
treatment for patients with short-bowel syndrome. … FDA
approves Gattex to treat short bowel syndrome.
[internet]. Silver Spring (MD): U.S. … Short bowel syndrome. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
February 01, 2016 - term)
and no effect (long
term)
5 RCTs (short
term) + 4 RCTs
(long term)
Low Small (short term … term)
Moderate Small (short and
long term)
1 SR (9 RCTs)
(short term) +
1 SR (7 RCTs)
(long term … short-acting opioids: Pain
Low Six trials found no clear differences between long-acting vs. short- … Short-wave
diathermy
Short-wave diathermy vs. … Short-wave diathermy:
Adverse events
Insufficient No study evaluated harms of short-wave diathermy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-research-executive-summ.pdf
April 01, 2025 - Parent-only
Posttreatment
13 RCTs
Moderate effect
++
9 RCTs
Moderate effect
++
Parent-only
Short … Multicomponent
Posttreatment
10 RCTs
Large effect
++
5 RCTs
Large effect
+
Multicomponent
Short … Parent-only
Posttreatment
11 RCTs
Small effect
++
7 RCTs
Moderate effect
+
Parent-only
Short … Posttreatment
2 RCTs
Insufficient evidence No evidence
Multicomponent
Multisystemic Therapy
Short … term
1 RCT
Insufficient evidence
No evidence
Multicomponent Family
Therapy
Short term